Background: Acinetobacter baumannii, a potential nosocomial pathogen has stealthily gained entry into the oral cavity. Their association with other pathogens like Pseudomonas aeruginosa in chronic and aggressive periodontitis cases is well documented. The magnitude of problem caused by A. baumannii could be attributed to resistance genes acquired by the organism. Since the microbiome of oral cavity is heterogeneous and complex, the transfer of genes from multidrug resistant A. baumannii may be a serious threat in infection control and management. In view of this fact, the present study aims to categorize and characterize drug resistant genes present in each of the 19 genomes of Acinetobacter Sp. selected for the study. Methods: About 19 genome sequences of Acinetobacter spp. with the predominance of different strains of A. baumannii was genotyped using in silico restriction digestion and pulse field gel electrophoresis (PFGE). Further, the prevalence of common drug resistant genes in the genome of various Acinetobacter spp. was recorded using in silico PCR analysis. Results: Based on the PFGE pattern, phylogenetic tree was constructed and the genomes were clustered into 6 genotypes. Genotype 4 (n ¼ 8; 42.10%) and 5 (n ¼ 6; 31.57%) were predominant, followed by genotypes 2 (n ¼ 2; 10.52%), 1, 3 and 6 (n ¼ 1; 5.26%). Three species were excluded from the list since they were negative for most of the drug resistant genes tested. Prevalence of drug resistant genes in each of the 16 genomes analysed found oxa-51, ISAba 1 and ADC 1 to be the major genes found in A. baumannii. Acinetobacter spp. belonging to genotypes 4 and 5 were found to harbour 6e10 and 2e8 potential drug resistant genes respectively. Conclusion: The present study showed cluster of multi-drug resistant genes in genomes analysed, thus, warranting the need for antibiotic surveillance, alternate therapeutic measures and development of novel antimicrobials. An extensive study on the genes conferring drug resistance in this pathogen will open new avenues for battling the entry and spread of this pathogen in vulnerable patient groups.
Introduction
A. baumannii, a Gram-negative cocco-bacilli has established itself as the most successful nosocomial pathogen within a short span of time with 2e10% of mortality rate recorded among patients with chronic urinary tract infections, bacteremia, pneumonia and critically ill patients in ICU [1] . The World Health Organization [WHO] have provided a red alert about the carbapenem resistant A. baumannii which secures its place under the "critical" category [2, 3] . An infamous fact about A. baumannii is its rapid evolution from multi-drug resistant [MDR] to extensively drug-resistant [XDR] form which has recently been escalated to pan-resistant
[PDR] status [4] . Innate resistance together with the ability to accommodate extrinsic resistance factors has contributed to the resurgence of this pathogen with utmost potential [5] .
The pathogen has been identified with much greater frequency in endodontic infections [6] along with other known dental pathogens. Prevalence of A. baumannii among patients with chronic or aggressive periodontitis is reported to be higher compared to the control group [7, 8] . The ability to form biofilm and resist desiccation is a key property of A. baumannii which makes it refractory to endodontic and periodontal treatments. The biofilms produced by the bacteria are also potential reservoirs of pathogens associated with pneumonia and chronic obstructive pulmonary disease [9, 10] . In a polymicrobial community, A.
baumannii protects carbapenems-susceptible bacteria, thus aggravating the disease process during treatment with carbapenems [11] . Although reports on A.
baumannii as a dental pathogen is minimal, the propensity of the pathogen to evolve with a drug resistant armour underscores the need for more research on this pathogen and its role in oral infections. Awareness about the evolution of this pathogen and its spread in the community settings should be monitored to avoid sudden outbreak.
The present study on this nosocomial pathogen aims to comprehend the drug resistant genes [DR] in the genomes of Acinetobacter sp. using in silico tools. Although the strains used in the study are not representatives of Acinetobacter sp. from the oral cavity, they represent a small subset of the multi-drug resistant pathogen evolving in the community. Hence, the in silico analysis delimits to the information that is available in the database and provides an alert on the growing concerns about emerging pathogens in dentistry. An extensive epidemiological investigation including samples from dental specimens is required to prove the role of A. baumannii in the development of oral diseases.
Methods

Strains used in the study
Genomes of strains used in the present study as retrieved from NCBI [National Centre for Biotechnology Information] database are given in Table 1 . A randomized subset comprising of nineteen isolates of genus Acinetobacter available in the database of in silico simulation tools for molecular biology experiments [http://insilico.ehu.es/PCR/] [12, 13] were used for drug resistant gene profiling.
PCR amplification
Primers for thirty seven commonly reported drug resistant genes were selected for the study and are summarized in Table 2 . In silico characterization and amplification of resistant genes were performed using in silico simulation tools for molecular biology experiments [12, 13] .
Pulse field gel electrophoresis [PFGE]
PFGE digestion of the selected genome was carried out using Apa I restriction enzyme, which recognizes the site 5 0 -GGGCCC-3 0 to produce cohesive end cleavage. The band pattern obtained after PFGE analysis was used to construct the phylogenetic tree [12, 13] . Lambda DNA ladder was used as a reference standard.
Results
Species confirmation
Acinetobacter baumannii was confirmed using 16S-23S ribosomal DNA intergenic spacer region which produced an amplicon size of 208bp upon in silico amplification using appropriate primers [ 
Phylogenetic analysis
PFGE was used for the construction of the phylogenetic tree. The restriction enzyme Apa I was used to cleave genomic DNA sequence of the selected strains and the dendrogram was obtained from the band patterns. Six genotypes [G1-G6] were classified based on strain similarities and were clustered into each of the genotypes [ Fig. 1 ]. Among the 6 genotypes [G], G4 was found to be the major genotype [n 
Discussion
When reports on methicillin-resistant Staphylococcus aureus, vancomycin-resistant
Enterococcus faecalis and multi-drug resistant Pseudomonas aeruginosa occupied a greater sector of the hospital acquired and community-based infections, a more potent pathogen emerged with mammoth abilities to combat almost all antibiotics of different generations. Acinetobacter baumannii, the critical pathogen, which was once considered to be opportunistic, has stealthily entered the oral cavity. Ignoring this pathogen and its drug-resistant gene repository would pose a serious threat while treating patients with soft tissue infections of the oral cavity. In line with the above facts, the present study was designed to characterize Acinetobacter sp. based on their PFGE pattern into genotypes and attribute frequencies of DR genes in each of the classified genotypes using computational tools. The results of 16S-23S ribosomal DNA intergenic spacer region [ITS] amplification was used to differentiate A. baumannii from other species such as A. pitti, A. oleivorans etc., which was coherent with the genotypic identification of Acinetobacter sp. from clinical samples [14] . The present in silico study showed 100% accuracy in detecting amplicons of ITS region specific for A. baumannii. PFGE was carried out to classify genotypes, which returned 2 major [G4 and G5] and 4 minor genotypes [G1, 2, 3, 6]. Development of resistance in pathogens to antimicrobials is threatening mankind. Intrinsic and extrinsic mechanisms act together to make the pathogen more and more potent against most of the available therapeutic drugs. finding in this study is that A. baumannii strain SDF was found to be PCR negative for an intrinsic bla Oxa-51-like gene. The probable reason might be the fact that this strain was isolated from the human body lice and is susceptible to almost all antibiotics [19] . ISAba1 belongs to class 1 integrons which is capable of transferring gene cassettes from one organism to the other. Interestingly, the presence of ISAba1 upstream of bla Oxa-51-like is known to increase the expression of the encoded enzyme by acting as a strong promoter. In the present study, 100% of strains belonging to G4 and 50% of G5 were found to possess ISAba1. bla Oxa-23-like was found in majority G4, G3 and one strain of G5, whereas bla Oxa58-like was found in a few strains of G4.
ampC type of beta-lactamase is naturally produced by Gram-negative bacteria. The enzyme is non-inducible and produced only at very low levels. In the presence of insertion elements, expression of ampC increases with the dissemination of genes thereby elevating the organism to a resistant state. The bla ADC [Acinetobacter derived cephalosporinases] gene encodes ampC b-lactamase, which in the presence of insertion elements ISAba1 or ISAba125, overproduces the enzyme. A comparative study on the placement of ISAba1 or ISAba125 on the upstream of bla ADC was carried out. It was found that expression of bla ADC was 6-times more when compared to constitutively expressed bla ADC with no upstream insertion element. The study also suggested the formation of hybrid gene which combines -10 promoter sequence of ISAba125 and -35 region of bla ADC gene which conferred resistance to cephalosporins [20] .
Numerous novel types of extended spectrum betaelactamase have emerged globally from which VEB [for Vietnamese extended-spectrum betaelactamase] family is one. The presence of bla VEB has been inconsistent with high prevalence [21] recorded in certain geographical locations and completely absent in a few others [22] . The present study records only one strain [A. The DR genes tetA and tetB encodes factors specific to efflux pump proteins that scavenge tetracycline from the cells [24] . Tet genes are mostly plasmid encoded and can easily be transferred to other closely related species [25] . While tetA confers resistance towards tetra and doxycycline, tetB includes resistance to minocycline also [26] . [27] , which recorded a prevalence of 13.6% of tetA and 66% of tetB. Another group of efflux system which enables A. baumannii to survive in the environment is the biocide efflux family, encoded by qac genes. qacED1 genes are widely propagated and disseminated through plasmid-mediated class I integrons [28] . High prevalence of qacED1 has been reported in clinical isolates of Acinetobacter making the organism resistant to both antibiotics as well as antiseptics [29] . The current study also records a high frequency of qacED1 gene in the isolates analyzed, with 100%, 87.5% and 33.3% in genotypes 3, 4, and 5 respectively. PCR positivity for carO gene was found to harbour about ten genes encoding drug resistance. The paradox identified needs further investigation to justify the relationship between the integrity of membrane proteins and the mechanism of drug resistance.
The alarming increase in the number of drug-resistant genes acquired by A. baumannii has made a significant impact in the community settings. On the other hand, the transfer of genes from the pathogen to other commensals intensifies the problem in treating diseases. Several characteristics of A. baumannii such as biofilm formation, ability to survive stressors, desiccation, makes it more suitable to gain entry into the oral cavity. Prosthetic devices, implants contaminated with the pathogen, may delay or even impede the treatment process. Since the oral cavity is loaded with a polymicrobial community, the ease of transfer of drug-resistant genes from one organism to other is remarkably high.
Conclusion
Intrinsic and extrinsic drug resistant mechanisms work parallely to produce a more stable and persistent strain of this pathogen. The remarkable drug-resistant profile of A. baumannii should not be overlooked as it may turn in to a greatest microbial menace in dentistry. Although the study addresses the major factors intended to be discussed, some of the limitations are [a] the phenotype and genotype correlation could not be performed due to lack of antimicrobial sensitivity data, Contributed reagents, materials, analysis tools or data; Wrote the paper.
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